Utpal Koppikar

Track

Insider profile

Currently holds a position at Atara Biotherapeutics Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Atara Biotherapeutics Inc June 7, 2018 -
Utpal Koppikar's trades of Atara Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
497.50
Quantity 3,960 +14.0%
Value US$817,833
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-06 2023-03-02
PlS Planned sale
79,269 +43.5%
32.93
US$23,760 		79,269 +43.5% 32.93 US$23,760
2023-02-10 2023-02-08
B Purchase
3,960 +14.0%
497.50
US$817,833 		3,960 +14.0% 497.50 US$817,833
2023-02-09 2023-02-07
PlS Planned sale
65,864 +12.6%
222.92
US$4,786,766 		65,864 +12.6% 222.92 US$4,786,766
2022-11-18 2022-11-16
PlS Planned sale
1,083 -0.6%
4.49
US$4,864 		1,083 -0.6% 4.49 US$4,864
2022-11-18 2022-11-16
PlS Planned sale
5,172 -2.6%
4.49
US$23,222 		5,172 -2.6% 4.49 US$23,222
2022-08-18 2022-08-16
PlS Planned sale
5,940 -2.9%
5.04
US$29,908 		5,940 -2.9% 5.04 US$29,908
2022-06-10 2022-06-08
PlS Planned sale
5,853 -2.8%
5.63
US$32,952 		5,853 -2.8% 5.63 US$32,952
2022-05-19 2022-05-17
PlS Planned sale
966 -0.5%
5.32
US$5,136 		966 -0.5% 5.32 US$5,136
2022-05-19 2022-05-17
PlS Planned sale
4,616 -2.2%
5.32
US$24,539 		4,616 -2.2% 5.32 US$24,539
2022-03-03 2022-03-01
PlS Planned sale
1,491 -0.7%
9.86
US$14,697 		1,491 -0.7% 9.86 US$14,697
2022-03-03 2022-03-01
PlS Planned sale
2,272 -1.0%
9.86
US$22,393 		2,272 -1.0% 9.86 US$22,393
2022-02-09 2022-02-07
PlS Planned sale
2,496 -1.6%
14.46
US$36,096 		2,496 -1.6% 14.46 US$36,096
2021-11-18 2021-11-16
PlS Planned sale
3,655 -2.3%
17.12
US$62,562 		3,655 -2.3% 17.12 US$62,562
2021-06-09 2021-06-08
PlS Planned sale
5,820 -3.4%
14.06
US$81,829 		5,820 -3.4% 14.06 US$81,829
2021-05-20 2021-05-18
PlS Planned sale
3,616 -2.1%
14.55
US$52,613 		3,616 -2.1% 14.55 US$52,613
2021-03-30 2021-03-26
PlS Planned sale
1,761 -1.0%
14.58
US$25,675 		1,761 -1.0% 14.58 US$25,675
2021-03-04 2021-03-02
PlS Planned sale
1,461 -0.8%
16.74
US$24,457 		1,461 -0.8% 16.74 US$24,457
2021-02-09 2021-02-08
PlS Planned sale
1,759 -1.3%
20.39
US$35,866 		1,759 -1.3% 20.39 US$35,866
2020-11-18 2020-11-17
PlS Planned sale
1,469 -1.1%
19.77
US$29,048 		1,469 -1.1% 19.77 US$29,048
2020-08-20 2020-08-18
PlS Planned sale
1,496 -1.1%
12.09
US$18,087 		1,496 -1.1% 12.09 US$18,087
2020-06-10 2020-06-09
PlS Planned sale
3,924 -2.8%
10.18
US$39,946 		3,924 -2.8% 10.18 US$39,946
2020-05-20 2020-05-18
PlS Planned sale
1,428 -1.0%
11.22
US$16,022 		1,428 -1.0% 11.22 US$16,022
2020-03-30 2020-03-27
PlS Planned sale
1,827 -1.3%
9.17
US$16,754 		1,827 -1.3% 9.17 US$16,754
2020-02-10 2020-02-06
PlS Planned sale
1,781 -2.4%
14.21
US$25,308 		1,781 -2.4% 14.21 US$25,308